1.98
9.39%
+0.17
iBio Inc Aktie (IBIO) Neueste Nachrichten
iBio Inc. stock rises Friday, outperforms market - MarketWatch
MarketWatch
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
MarketWatch
iBio Inc. stock remains steady Wednesday, underperforms market - MarketWatch
MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
MarketWatch
IBIO Stock Earnings: iBio Reported Results for Q3 2024 - InvestorPlace
InvestorPlace
iBio Inc. stock falls Monday, underperforms market - MarketWatch
MarketWatch
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
GlobeNewswire
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire Inc.
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
MarketWatch
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
MarketWatch
iBio Inc. stock falls Monday, underperforms market - MarketWatch
MarketWatch
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
MarketWatch
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
MarketWatch
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble - InvestorPlace
InvestorPlace
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
MarketWatch
iBio Inc. Raises $15M in Private Placement and Issues Warrants - TipRanks.com - TipRanks
TipRanks
iBio Inc. stock falls Monday, underperforms market - MarketWatch
MarketWatch
iBio enters collaboration agreement with AstralBio - TipRanks.com - TipRanks
TipRanks
Balancing Volatility With Stability When Trading Penny Stocks
PennyStocks
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
GlobeNewswire Inc.
iBio partners with AstralBio to develop obesity treatments using AI-driven platform - Proactive Investors USA
Proactive Investors USA
iBio Announces $15.0 Million Private Placement
GlobeNewswire Inc.
iBio secures $15 million in PIPE financing deal By Investing.com - Investing.com
Investing.com
iBio Inc. stock rises Friday, outperforms market - MarketWatch
MarketWatch
iBio Inc. stock rises Monday, outperforms market - MarketWatch
MarketWatch
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
GlobeNewswire Inc.
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka - GlobeNewswire
GlobeNewswire
Thinking about buying stock in Ibio Inc, Nokia, C4 Therapeutics, 1847 Holdings, or CleanSpark? - Marketscreener.com
Marketscreener.com
iBio Announces Participation in 23rd Annual PepTalk Conference
GlobeNewswire Inc.
Top 4 Health Care Stocks That May Rocket Higher In Q1
Benzinga
iBio Amends and Extends Maturity of Credit Agreement
GlobeNewswire Inc.
Crude Oil Moves Lower; AutoZone Profit Tops Views
Benzinga
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Dow Falls 100 Points; ISM Services PMI Increases In November
Benzinga
US Stocks Down; JM Smucker Posts Upbeat Earnings
Benzinga
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Is iBio (IBIO) Stock Down 41% Today? - InvestorPlace
InvestorPlace
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
iBio Announces Reverse Stock Split
GlobeNewswire Inc.
iBio Announces Reverse Stock Split - Yahoo Finance
Yahoo Finance
Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done - InvestorPlace
InvestorPlace
Day 5 of Loss Streak for iBio Stock with -33% Return (vs. 1.3% YTD) [8/11/2023] - Trefis
Trefis
iBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO to Oversee Company's Next Stage of Growth - GlobeNewswire
GlobeNewswire
Long-Term Biotech Stock Investments: 3 That May Make You a MIllionaire - InvestorPlace
InvestorPlace
iBio Forges Research Collaboration with the National Institutes of Health - GlobeNewswire
GlobeNewswire
Spin Me Round: iBio Reemerges as Innovator of Precision Antibody Immunotherapies - Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform - Yahoo Finance
Yahoo Finance
iBio Advances Anti-CCR8 Antibody Program to Preclinical In Vivo Testing - GlobeNewswire
GlobeNewswire
Kapitalisierung:
|
Volumen (24h):